Private Market View

Neowise Biotechnology

Suzhou, China · Founded 2020 · Privately Held (backing)

Last price · $/share
Implied valuation
$229.1M
Total raised
$57.1M
Last round
What is Neowise Biotechnology worth?
$229.1Mlast known valuation
Free account
See the evidence behind this price
  • ·The complete investor list — 15 names
  • ·Watchlist + deal alerts for Neowise Biotechnology
  • ·The full record, as it builds
Create free account
No card required

Funding history

No rounds on record

No funding rounds for Neowise Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Neowise Biotechnology's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Neowise Biotechnology, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Neowise Biotechnology worth?
Neowise Biotechnology's last known valuation is $229.1M.
How much has Neowise Biotechnology raised?
Neowise Biotechnology has raised $57.1M in total funding across its recorded rounds.